Life Sciences
Sunresin Opens Its First European Site in Uppsala

New facility will focus on chromatography resin development, process development and closer technical support for European Life Sciences customers

Sunresin has officially opened its first European site in Uppsala, Sweden, marking an important step in the company’s international growth and its long-term commitment to the European biopharmaceutical and Life Sciences industries.

The new facility, located at Uppsala Business Park, will serve as a European centre for chromatography resin development, process development, technical support and customer collaboration.

Uppsala was selected for its long-standing expertise in chromatography and bioprocessing, as well as its close network of pharmaceutical companies, universities, research organisations and biotechnology startups.

The Grand Opening brought together customers, partners, researchers, industry experts and local representatives for a full day of scientific discussion, facility tours and celebration. The event also marked Sunresin’s 25th anniversary, connecting the company’s history with the opening of a new chapter in Europe.

“Our ambition for the Uppsala site is to support both resin development and process development for the pharmaceutical industry, while creating opportunities to work closely with academia, research institutes and biotechnology companies,” said Hans Johansson, General Manager of Sunresin Sweden. “Uppsala gives us the scientific environment and experience needed to build those collaborations.”

 

The scientific program focused on several areas shaping the future of bioprocessing. Jonathan Royce discussed how the growing diversity of molecular structures is changing protein purification. Mats Lundgren presented developments in mucosal vaccines and the potential advantages of cold-chain-free solutions. Tiago Matos explored the transition from reactive to predictive pharmaceutical manufacturing, while Cecilia Lindskog presented the Human Protein Atlas and its relevance to biomarker research, drug development and human biology.

The program also included presentations from Sunresin management, guided tours of the new laboratories and application areas, and an official ribbon-cutting ceremony attended by representatives from Uppsala and international guests.

“The opening of our first European site brings Sunresin closer to customers and partners across the region,” said Xiaokang Kou, CEO of Sunresin. “It creates a local platform for technical collaboration while connecting Sunresin’s global manufacturing capabilities with the scientific expertise already present in Uppsala.”

The day concluded with a gala dinner celebrating both the opening of Sunresin Sweden and the company’s 25th anniversary.

With more than 1,400 employees, Sunresin develops and manufactures chromatography, ion exchange, adsorbent, solid-phase synthesis and specialty resin technologies for pharmaceutical, biotechnology, food, environmental and chemical applications.

The opening of the Uppsala site strengthens Sunresin’s ability to support European customers with local technical expertise, application development and closer collaboration throughout process development and scale-up.

Media Contact

Hans Johansson
General Manager, Sunresin Sweden
hans.johansson@sunresin.se
+46706120445